Altrafin AG’s Morgan Stanley MS Stock Holding History
Bought
Maintained
Sold
Other funds holding MS
Altrafin AG's MS Position: Q1 2025 in Review
Altrafin AG sold out of Morgan Stanley (MS) in Q1 2025, closing a stake of 15,200 shares — an estimated $1.91M sold.
Altrafin AG first reported a position in MS in Q4 2021 and held it in 13 quarters. The position peaked at $2.42M in Q1 2023. 2,104 funds tracked by Wall St. Rank hold MS as of Q1 2025.
- Altrafin AG reported no remaining Morgan Stanley position as of Q1 2025 after selling out during the quarter.
- Altrafin AG sold 15,200 Morgan Stanley shares in Q1 2025, an estimated $1.91M.
- Altrafin AG first reported a position in Morgan Stanley in Q4 2021 and held it in 13 quarters.
- Altrafin AG's Morgan Stanley position peaked at $2.42M in Q1 2023.
- 2,104 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2025.
Based on Altrafin AG's 13F filing for Q1 2025, filed 17 Feb 2026.